CliffBio
small molecule

TRYPTYR

ACOLTREMON

Loss of exclusivityDecember 2042latest FDA-listed patent expiry
CompanyAlcon →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRYPTYR
Active ingredientACOLTREMON
Strength0.003%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalMay 2025
Marketing statusRX

Listed patents

PatentExpiresType
11850221December 2042product
12336971December 2042use U-1900
10028920September 2031use U-1900
9433679September 2031use U-1900
9095609September 2031product

Regulatory exclusivity

CodeExpires
NCEMay 2030

More from Alcon

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TRYPTYR patent cliff — loss of exclusivity December 2042 | CliffBio